Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1993-04-06
1995-12-19
Parr, Margaret
Chemistry: molecular biology and microbiology
Spore forming or isolating process
5303872, 5303884, 5303882, 5303875, 4352402, 4351722, 435 702, 435 732, C12N 512, C12N 1502, C07K 1642, C07K 1618
Patent
active
054767849
ABSTRACT:
The present invention relates to anti-idiotypic antibodies directed against Neisseria gonorrhoeae. This invention also relates to methods and compositions using such anti-idiotypic antibodies for the prophylaxis, treatment and diagnosis of gonorrheal infections.
REFERENCES:
patent: 4699880 (1987-10-01), Goldstein
Harris, W. J. et al., TiBTECH, 11:42-44, Feb. 1993.
Stone, B., Science, 259:1243, 26 Feb. 1993.
Fitzer-Schiller, G., The Washington Post, D3, Jan. 19, 1993.
Spaulding, B. J., Bio/Technology, 11:428-429, Apr. 1993.
Waldmann, T. A., Science, 252:1657-1662, 21 Jun. 1991.
Brossay, L. et al., J. Immunology, 151(1):234-243, Jul., 1993.
Kennedy, R. C. et al., BioTechniques, 3(5):404-409, 1985.
Morrison, Sherie L., Science, 229:1202-1207, 1985.
Queen, C. et al, PNAS, 86:10029-10033, Dec. 1989.
Apicella, M. A., M. A. J. Westerink, S. A. Morse, H. Schneider, P. A. Rice and J. M. Griffiss. 1986. Bactericidal antibody response of normal human serum to the lipooligosaccharid Neisseria gonorrhoeae. J. Infect. Dis. 153:520-526.
Apicella, M. A., R. E. Mandrell, M. Shero, M. E. Wilson, J. McLeod Griftis, G. F. Brooks, C. Lamarel, J. F. Breen and P. A. Rice. 1990. Modification of sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. J. Infect. Dis. 162:506-512.
Britigan, B. E., M. S. Cohen and P.F. Sparling. 1985. Gonococcal infection: a model of molecular pathogenesis. N. Eng. J. Med. 312:1683-1694.
Brodin, N. T., J. Dahmen, B. Nilsson, L. Messter, S. M.ang.rtenson, J. Heldrup, H. O. Sjogren and A. Lundblad. 1988. Monoclonal antibodies produced by immunization with neoglycoproteins containing Gal.alpha.1.fwdarw.4.beta.1.fwdarw.4G1c.beta.-O and Gal.alpha.1.fwdarw.4.beta.1.fwdarw.4G1cNAc.beta.-O residues: useful immunochemical and cytochemical reagents for blood group P antigens and a differentiation marker in Burkitt lymphoma and other B-cell malignancies. Int. J. Cancer. 42:185-194.
Brooks, G. F. and C. J. Lammel. 1989. Humoral immune response to gonococcal infection. Clin. Micro. Rev. 2:S5-S10.
Brossay, L., G. Paradis, A. Pepin, E. Gagnon, L. Cote, J. Hebert. 1992. Poster Presentation II-4, p. 148, The Eighth International Pathogenic Neisseria Conference, Oct. 4-9, 1992 (Cuernavaca, Mexico).
CDC. 1991. Pelvic Inflammatory Disease: Guidelines for Prevention and Management. MMWR 40:1-25.
CDC. 1982. Sexually transmitted diseases treatment guidelines. MMWR 31:37S-42S 375-425.
CDC. 1984. Chromosomally mediated resistant Neisseria gonorrhoeae-United States. MMWR 33:408-410.
Cohen, I. R., D. S. Kellogg and L. C. Norins. 1969. Serum antibody response in experimental human gonorrhoeae: immunoglobulins G, A and M. Br. J. Ven. Dis. 45:325-327.
Densen, P., S. Gulati and P. A. Rice. 1987. Specificity of antibodies against Neisseria gonorrhoeae that stimulate neutrophil chemotaxis. J. Clin. Invest. 80:78-87.
Fohn, M. J., T. A. Mietzner, T. W. Hubbard, S. A. Morse and E. W. Hook III. 1987. Human immunoglobulin G antibody response to the major gonococcal iron-regulated protein. Infect. Immun. 55:3065-3069.
Glynn, A. A. and M. E. Ward. 1970. Nature and heterogeneity of the antigens of Neisseria gonorrhoeae involved in the serum bactericidal reaction. Infect. Immun. 2:162-168.
Gnehm, H. E., S. I. Pelton, S. Gulati and P. A. Rice. 1985. Characterization of antigens from nontypable Haemophilus influenzas recognized by human bactericidal antibodies. J. Clin. Invest. 75:1645-1658.
Griffiss, H. M., J. P. O'Brien, R. Yamasaki, G. D. Williams, P. A. Rice and H. Schneider. 1987. Physical heterogeneity of Neisserial lipooligosaccharides reflects oligosaccharides that differ in apparent molecular weight, chemical composition, and antigenic expression. Infect. Immun. 55:1792-1800.
Jerne, N. I. 1974. Towards a network theory of the immune system. Ann. Immun. Inst. Pasteur. 125C:373-389.
Joiner, K. A., R. Scales, J. A. Warren, M. M. Frank and P. A. Rice. 1985. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. Clin. Invest. 76:1765-1772.
Kasper, D. L., P. A. Rice and W. M. McCormack. 1977. Bactericidal antibody in genital infection due to Neisseria gonorrhoeae. J. Infect. Dis. 135:243-251.
Kennedy, R. C., K. Adler-Storthe, R. D. Henkel, Y. Sanchez, J. L. Melnick and G. R. Dreesman. 1983. Immune response to hepatitis B surface antigen: enhancement by prior injection of antibodies to the idiotype. Science 221:853-855.
Kennedy, R. C., J. W. Eichberg, R. E. Landford and G. R. Dressman. 1986. Anti-idiotypic vaccine for type B viral hepatitis in chimpanzees. Science 232:220-223.
Kieber-Emmons, T., R. E. Ward, S. Raychaudhuri, R. Rein and H. Kohler. 1986. Rational design and application of idiotope vaccines. Int. Rev. Immunol. 1:1-26.
Kim, J. J., R. E. Mandrell, H. Zhen, M. A. J. Westerink, J. T. Poolman and J. M. Griffiss. 1988. Electromorphic characterization and description of conserved epitopes of the lipooligosaccharides of group A Neisseria meningitidis. Infect. Immun. 56:2631-2638.
Lambden, P. R., J. E. Heckels, H. McBride and P. J. Watt. 1981. The identification and isolation of novel pilus types produced by variants of Neisseria gonorrhoeae P9 following selection in vivo. FEMS. Microbiol. Lett. 10:339-341.
Lammel, C. J., R. L. Sweet, P. A. Rice, J. S. Knapp, G. K. Schoolnik, D. C. Heilbron and G. F. Brooks. 1985. Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. J. Infect. Dis. 152:990-1001.
Mandrell, R. E., H. Schneider, M. A. Apicella, W. D. Zollinger, P. A. Rice and J. M. Griffiss. 1986. Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharides. Infect. Immun. 54:63-69.
Mandrell R. E., J. M. Griffiss and B. E. Macher. 1988. Lipooigosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens: carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes. J. Exp. Med. 168:107-126.
Mandrell, R. E. 1992. Further antigenic similarities of Neisseria gonorrhoeae lipooligosaccharides and human glycosphingolipids. Infect. Immun. 60:3017-3020.
Morse, S. A., S. Stein and J. Hines. 1974. Glucose metabolism in Neisseria gonorrhoeae. J. Bact. 120:702-714.
Newhall, W. J., W. D. Sawyer, and R. A. Haak. Cross-linking analysis of the outer membrance proteins of Neisseria gonorrhoeae. Infect. Innum. 28:785-791.
Nisonoff, A. and E. Lamoyi. 1981. Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: possible application to vaccine production. Clin. Immunol. Immunopathol. 21:397-406.
Rice, P. A. and D. L. Kasper. 1977. Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection. J. Clin. Invest. 60:1149-1158.
Rice, P. A. and D. L. Kasper. 1982. Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. J. Clin. Invest. 70:157-167.
Rice. P. A., H. E. Vayo, M. R. Tam and M. S. Blake. 1986. Immunoglobulin G antibodies directed against protein III block killing of serum resistant Neisseria gonorrhoeae by immune serum. J. Exp. Med. 164:1735-1748.
Rice, P. A. 1989. Molecular basis for serum resistance in Neisseria gonorrhoeae. Clin. Micro. Rev. 2S:S112-S117.
Roberts, R. B. 1967. The interaction in vitro between Group B meningococci and rabbit polymorphonuclear leukocytes. J. Exp. Med. 126:795-817.
Ross, S. C. and P. Densen. 1985. Opsonophagocytosis of Neisseria gonorrhoeae: interaction of local and disseminated isolates with complement and neutrophils. J. Infect. Dis. 151:33-41.
Schoolnik, G. K. and Mietzner, T. A. 1992. Vaccines against gonococcal infections. In: G. C. Woodrow and M. M. Levine (ed.), New Generation Vaccines, Marcel Dekker, Inc. New York, 565-597.
Schoolnik, G. K. and Z. A. McGee. 1985. Gonococcal vaccine development strategies: summary of the recommendations of a National Institutes of Health vaccine panel. In: G. K. Schoolnik, G. F. Brooks, S. Falko
Gulati Sunita
McQuillen Daniel P.
Rice Peter A.
Loring Susan A.
Parr Margaret
Pierri Margaret A.
Thampoe Immac J.
LandOfFree
Gonococcal anti-idiotypic antibodies and methods and composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gonococcal anti-idiotypic antibodies and methods and composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gonococcal anti-idiotypic antibodies and methods and composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-991696